DRUG MECHANIS INDICATION CONTRAINDICAT ADVERSE EFFECT NURSING

NAME M OF ION CONSIDERATI

ACTION ON
Ceftriaxon >Inhibits cell >UTI, lower >Contraindicate >GI: >Monitor
e wall respiratory d in patients pseudomembranous patients for
Dosage: synthesis, tract, hypersensitive colitis, diarrhea, superinfectio
2g promoting gynecologic, to drug or other hematologic, n, diarrhea
IV osmotic bones or cephalosporins. cosinophilia,thrombocy and anemia
(OD) instability, joint, tosis, leukopenia. and treat
Therapeuti usually intraabdomin >Use cautiously appropriately
c bactericidal. al. in patients .
Classificati hypersensitive
on: >Meningitis to penicillin
Antibiotics because of
>Perioperativ possibility of
e prophylaxis cross-sensitivity
with other beta-
>Acute lactam
bacterial otitis antibiotics.
media
Atorvastati >Inhibits >In patients >Contraindicate >CNS: insomnia >Patient
n HMG-CoA with clinically d in patients should follow
Dosage: reductase, evident CAD, hypersensitive >EENT: a standard
80mg an early step to reduce risk to drug and in nasopharyngitis, cholesterol-
1Tab in of nonfatal those with pharyngolaryngeal lowering diet
(ODHS) cholesterol MI, fatal and active liver pain. before and
Therapeuti biosynthesis nonfatal disease or during
c . strokes, unexplained >GI: abdominal pain, theraphy.
Classificati angina, and persistent diarrhea, dyspepsia,
on: reverse elevations of flatulence, nausea. >Teach
Antilipemi revascularizati transaminase patient about
cs on levels. >GU: UTI proper
procedures. dietary
>Use cautiously management
>To reduce in patients with , weight
risk of MI or hepatic control and
stroke in impairement or exercise.
patiens with heavy alcohol
type 2 use, in patients >Tell patient
diabetes and with to inform
multiple risk inadequately prescriber of
factors for treated all adverse
CAD but who hypothyroidism, reactions,
don’t yet have with other drugs such as
the disease. associated with muscle pain,
myopathy and in malaise and
elderly patients. fever.
Omeprazol >Inhibits >Helicobacter >Contraindicate >CNS: asthenia, >Monitor
 e proton pylori d in patients dizziness, headache. patient for
Dosage: pump infection and hypersensitive sign and
40mg activity by duodenal to drug or its >GI: abdominal pain symptoms of
1Cap binding to ulcer disease, components and constipation, diarrhea, acute
(OD) hydrogen- to eradicate in patients flatulence, nausea, interstitial
Therapeuti potassium H. pylori with receiving vomiting, acid nephritis.
c adenosine clarithromyci rilpivirine- regurgitation.
Classificati triphosphat n. containing >Instruct
on: ase, located products. patient to
Antiulcer at secretory >Short-term take drug
drugs surface of treatment of >Use cautiously atleast
gastric active benign in patients with 30mins to
parietal gastric ulcer. hypokalemia 60mins
cells, to and respiratory before meals.
suppress alkalosis and in
gastric acid patients on a >Give
secretion. low-sodium diet. patients
instructions
on how to
take oral
suspension.
Azithromy >Binds to >Acute >Contraindicate >CNS: fatigue, >Monitor
cin the 50S bacterial d in patients headache, patient for
Dosage: subunit of worsening of hypersensitive somnolence, dizziness. superinfectio
500mg bacterial COPD caused to azithromycin, n. Drug may
1Tab ribosomes, by erythromycin, or >CV: chest pain, cause
(OD) blocking Haemophilus other macrolide palpitation. overgrowth
Therapeuti protein influenza, or ketolide of
c synthesis, Streptoccus antibiotics and >EENT: eye irritation nonsusceptib
Classificati bacteriostati pneumonia in those with le bacteria or
on: c or and history of >GI: abdominal pain, fungi.
Antibiotics bactericidal, uncomplicate cholesterol anorexia, diarrhea,
depending d skin and jaundice or nausea , vomiting, >Tell patient
on skin- hepatic pseudomembranous to take drug
concentratio structure dysfunction colitis, dyspepsia, as prescribd,
n. infections. from prior use flatulence, melena. even after
of azithromycin. feeling
>Single dose >GU: candidiasis, better.
treatment for >Use cautiously nephritis, vaginitis.
mild to in patient with >Tell patient
moderate impaired to report
acute hepatic function adverse
bacterial or myasthenia reactions
sinusitis gravis. promptly.

Clopidogre >Inhibits the >To reduce >Contraindicate >CNS: confussion, fatal >Advise
l binding of rate of MI and d in patients intracranial bleeding, patient that
Dosage: ADP to its stroke in hypersensitive hallucination, it may take
 75mg platelet patients with to drug or its headache longer than
1Tab receptor, established components, in usual to stop
(OD) impending peripheral those with a >CV: hypotension, bleeding and
Therapeuti ADP- arterial history of hemorrhage at any to refrain
c mediated disease or hypersensitivity site. from
Classificati activation history of or hematologic activities in
on: and recent MI or reaction to >EENT: epistaxis, which
Antiplatele subsequent stroke. other rhinitis, taste disorder. trauma and
t drugs platelet thienopyridines, bleeding may
aggregation >To reduce and in those >GI: hemorrhage, occur.
and rate of MI and with pathologic abdominal pain,
irreversibly stroke in bleeding. constipation, diarrhea, >Instruct
modifies the patients with dyspepsia, gastritis, patient to
platelet ADP unstable >Use cautiously ulcers. notify
receptor. angina/non- in patients at prescriber if
ST- elevation risk for >GU: UTI, hematuria unusual
MI, including increased bleeding or
those manage bleeding from bruising
medically and trauma, surgery occurs.
those or other
managed with pathologic >Inform
coronary conditions and patient that
revascularizati in those with drug may be
on. renal or hepatic taken
impairmaent. without
regard to
meals.